Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
Journal Title: Turkish Journal of Hematology - Year 2011, Vol 28, Issue 1
Abstract
Objective: This study aimed to examine the incidence, clinical characteristics, and outcome of hyperuricemia and tumor lysis syndrome (TLS) in children with non-Hodgkin’s lymphoma (NHL) and acute lymphoblastic leukemia (ALL). Materials and Methods: This retrospective study included data from 327 patients (113 NHL and 214 ALL). Results: Hyperuricemia occurred in 26.5% and 12.6% of the patients with NHL and ALL, respectively. The corresponding figures for TLS were 15.9% and 0.47% (p=0.001). All hyperuricemic NHL patients had advanced disease and renal involvement was present in 53%. All hyperuricemic ALL patients had a leukocyte count >50,000 mm3 at the time of diagnosis. Among the hyperuricemic NHL and ALL patients, 96.6% and 66.6% had LDH ≥500 UI/L, respectively. Treatment consisted of hydration and allopurinol; none of the patients received urate oxidase. Among the patients that developed TLS, 26.3% had laboratory TLS, 42.1% had grade I or II TLS, and 31.6% had grade III or IV TLS. Uric acid levels returned to normal after a mean period of 3.5±2.5 and 3.05±0.8 d in NHL and ALL groups, respectively. In all, 7% of the patients with hyperuricemia required hemodialysis. None of the patients died. Conclusion: In this series the factors associated with a high-risk for TLS were renal involvement in NHL and high leucocyte count in ALL. Management with allopurinol and hydration was effective in this group of patients with high tumor burden.
Authors and Affiliations
Betül Sevinir, Metin Demirkaya, Birol Baytan, Adalet Güneş
Keywords
Related Articles
- EP ID EP85348
- DOI -
- Views 117
- Downloads 0
Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study
Objective: Any erythrocyte transfusion among humans having type A or B blood groups is impossible due to antibodies causing fatal transfusion complications. A cross-match test is performed to prevent immune transfusion c...
Endothelial Protein C Receptor gene Expression in a Female with Homozygous EPCR gene 23-bp Insertion
Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms
Objective: Chronic myeloproliferative neoplasms (CMPNs) that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are Philadelphia-negative malignancies characterized by a clona...
Çocukluk Çağı Akut Lenfoblastik Lösemisi’nde Tanı Zamanının Mevsimsel Farklılıkları ile Prognoz Arasındaki İlişki
Depletion of innate immunity or bone marrow suppresion by viral infection ?